Abundant tissue microarray and immunohistochemistry data suggested that GPC3 (a subtype of HSPG) protein expressed highly in over 70% of HCC tumor samples, but none in normal liver tissue, benign liver disease, liver cirrhosis and hepatitis tissues [11–13]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.